Medication info

Arosartan Tablet 10/50 mg

Prescription medicationTabletOralExpired
Ingredient · strength
Amlodipine Besylate›13.888mg / 1 tabletLosartan Potassium›50mg / 1 tablet
Manufacturer / importer
(Co., Ltd.) Ilhwa
Appearance
Light pink rectangular film-coated tablet
Packaging
30 tablets per bottle, 300 tablets per bottle
Approval status
Expired

MFDS item code 201903028 · Approved 2019.05.10

This product's status changed to Expired on 2024.05.10. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Essential hypertension, initial treatment of stage 2 hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended to take the tablet at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. - 5/50 milligrams: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 milligrams or losartan 50 milligrams. - 5/100 milligrams: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 milligrams or losartan 100 milligrams. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should be based on factors such as baseline blood pressure, target blood pressure, and the expected extent to which the combination product will achieve the treatment goal compared with monotherapy. The usual dose is 5/50 milligrams once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 milligrams once daily. ○ Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or patients receiving dialysis. ○ Patients with reduced effective intravascular volume: Use of this medicine is not recommended in a small number of patients with reduced effective intravascular volume (e.g., patients receiving treatment with high-dose diuretics). (See section 1, Warnings, in Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 milligrams once daily). ○ Elderly patients: In patients aged 75 years or older, an initial losartan dose of 25 milligrams once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.
Child dose
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
(Co., Ltd.) Ilhwa

Efficacy & effects

Essential hypertension, initial treatment of stage 2 hypertension

  • Essential hypertension
  • Stage 2 hypertension
View approved original text

This medication is used for patients with essential hypertension whose blood pressure is not well controlled with monotherapy. It is also used as a first-line treatment for Stage 2 hypertension patients who require combination therapy to reach their target blood pressure. Therefore, this drug helps effectively treat hypertension by improving blood pressure control.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended to take the tablet at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. - 5/50 milligrams: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 milligrams or losartan 50 milligrams. - 5/100 milligrams: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 milligrams or losartan 100 milligrams. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should be based on factors such as baseline blood pressure, target blood pressure, and the expected extent to which the combination product will achieve the treatment goal compared with monotherapy. The usual dose is 5/50 milligrams once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 milligrams once daily. ○ Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or patients receiving dialysis. ○ Patients with reduced effective intravascular volume: Use of this medicine is not recommended in a small number of patients with reduced effective intravascular volume (e.g., patients receiving treatment with high-dose diuretics). (See section 1, Warnings, in Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 milligrams once daily). ○ Elderly patients: In patients aged 75 years or older, an initial losartan dose of 25 milligrams once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.

Child dose

○ Children: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This drug can cause serious harm to the fetus during pregnancy, particularly in the second and third trimesters, and should never be taken during pregnancy. It should be discontinued immediately upon confirmation of pregnancy. Hypotension may occur when initially administering this drug to patients with reduced blood volume, so the condition must be well managed in advance. This drug should not be used in patients who are allergic to any of its components or those with severely impaired liver function, severe aortic stenosis, or patients in shock. Caution is advised in patients with high serum potassium levels or severely impaired kidney function, and regular blood tests should be conducted to monitor their condition. Dizziness or drowsiness may occur during the use of this drug, so it is advisable to avoid driving or operating dangerous machinery. Pregnant or nursing women should not use this drug, especially during breastfeeding, due to the possibility of drug transfer into breast milk. Safety and efficacy in children and adolescents under 18 years of age have not been established, and its use is not recommended. Elderly patients, especially those over 75 years, require initial dose adjustments, and the combination of this drug is not recommended. Caution is needed when used with other antihypertensive agents, as the blood pressure-lowering effect may be enhanced. Concomitant use with grapefruit juice may increase the serum concentration of the drug, so it is advisable to avoid this combination. In cases of overdose, serious hypotension and cardiac function deterioration may occur, thus immediate medical treatment is required. This drug should be stored out of reach of children, and changing the container is not recommended as it may affect product quality.

Side effects

  • Hypotension
  • neonatal skull formation deficiency
  • anuria
  • renal failure
  • oligohydramnios
  • fetal limb contraction
  • craniofacial deformity
  • pulmonary hypoplasia
  • immature
  • intrauterine growth retardation
Show 196 more
  • patent ductus arteriosus
  • dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • weakness
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • pit edema
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux disease
  • constipation
  • pruritus
  • urticaria
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • vertigo
  • conjunctival injection
  • frequent urination
  • fatigue
  • edema
  • dizziness
  • abdominal pain
  • nausea
  • weakness
  • lethargy
  • pain
  • weight gain
  • weight loss
  • hypotension
  • vasculitis
  • tension increase
  • sensory reduction
  • sensory abnormalities
  • peripheral neuropathy
  • syncope
  • taste disturbance
  • tremor
  • erectile dysfunction
  • gynecomastia
  • change in bowel habits
  • dry mouth
  • gastritis
  • gingival hypertrophy
  • pancreatitis
  • vomiting
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • rhinitis
  • hair loss
  • increased sweating
  • purpura
  • skin discoloration
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urinary frequency
  • urinary disorders
  • nocturnal enuresis
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • erythematous skin rash
  • spotty papular rash
  • heaviness
  • heat sensation
  • impaired glucose tolerance
  • weakness
  • muscle cramps
  • low back pain
  • leg pain
  • congestion
  • upper respiratory tract infection
  • sinusitis
  • diarrhea
  • sinus disorders
  • pharyngitis
  • myalgia
  • insomnia
  • ascites
  • abdominal pain
  • angioedema
  • peeling skin phenomenon
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • tachycardia
  • bradycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • appetite loss
  • toothache
  • flatulence
  • gastritis
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory loss
  • decreased libido
  • memory impairment
  • migraine
  • nervous irritability
  • panic disorder
  • sleep disturbance
  • tremor
  • bronchitis
  • throat discomfort
  • nasal bleeding
  • rhinitis
  • respiratory congestion
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • photosensitivity
  • sweating
  • urticaria
  • blurred vision
  • burning sensation and pain in the eyes
  • conjunctivitis
  • taste distortion
  • tinnitus
  • vision impairment
  • nocturnal enuresis
  • urethral infection
  • dry cough
  • angioedema
  • vasculitis
  • anaphylactic reaction
  • hepatitis
  • liver function abnormalities
  • lethargy
  • anemia
  • thrombocytopenia
  • rhabdomyolysis
  • taste disorder
  • erythroderma
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • decreased blood pressure
  • shock symptoms
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • anaphylactic shock syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is safe to store at room temperature between 1 degree and 30 degrees. Therefore, it is important to avoid storing it in extremely hot or cold places and to keep it in an environment with appropriate temperatures.

Appearance and packaging

Appearance

Light pink rectangular film-coated tablet

Package unit

30 tablets per bottle, 300 tablets per bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.